全文获取类型
收费全文 | 58077篇 |
免费 | 5494篇 |
国内免费 | 2607篇 |
专业分类
耳鼻咽喉 | 225篇 |
儿科学 | 3488篇 |
妇产科学 | 717篇 |
基础医学 | 4869篇 |
口腔科学 | 529篇 |
临床医学 | 5665篇 |
内科学 | 10642篇 |
皮肤病学 | 636篇 |
神经病学 | 1820篇 |
特种医学 | 1434篇 |
外国民族医学 | 6篇 |
外科学 | 22049篇 |
综合类 | 6951篇 |
现状与发展 | 15篇 |
一般理论 | 3篇 |
预防医学 | 1224篇 |
眼科学 | 1307篇 |
药学 | 2042篇 |
12篇 | |
中国医学 | 473篇 |
肿瘤学 | 2071篇 |
出版年
2024年 | 61篇 |
2023年 | 783篇 |
2022年 | 869篇 |
2021年 | 1908篇 |
2020年 | 2001篇 |
2019年 | 2203篇 |
2018年 | 2217篇 |
2017年 | 2098篇 |
2016年 | 1971篇 |
2015年 | 1950篇 |
2014年 | 3303篇 |
2013年 | 3857篇 |
2012年 | 2810篇 |
2011年 | 3485篇 |
2010年 | 3158篇 |
2009年 | 3246篇 |
2008年 | 3316篇 |
2007年 | 3524篇 |
2006年 | 3528篇 |
2005年 | 3072篇 |
2004年 | 2551篇 |
2003年 | 2160篇 |
2002年 | 1717篇 |
2001年 | 1466篇 |
2000年 | 1238篇 |
1999年 | 980篇 |
1998年 | 905篇 |
1997年 | 769篇 |
1996年 | 734篇 |
1995年 | 610篇 |
1994年 | 661篇 |
1993年 | 368篇 |
1992年 | 476篇 |
1991年 | 364篇 |
1990年 | 238篇 |
1989年 | 233篇 |
1988年 | 233篇 |
1987年 | 167篇 |
1986年 | 140篇 |
1985年 | 182篇 |
1984年 | 124篇 |
1983年 | 76篇 |
1982年 | 89篇 |
1981年 | 75篇 |
1980年 | 60篇 |
1979年 | 43篇 |
1978年 | 55篇 |
1977年 | 34篇 |
1976年 | 31篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
移植肝缺血-再灌注损伤程度的评估及其与肝移植患者预后的关系 总被引:3,自引:1,他引:2
目的探讨移植肝缺血-再灌注损伤程度的评估方法及其与肝移植患者预后的关系。方法218例良性终末期肝病患者,在移植肝恢复血液灌注后1h采取外周静脉血,测定丙氨酸转氨酶浓度(定义为基础肝功能),同时采用组织气体分析仪测定肝组织的氧分压,并取肝组织活检,计算水变性及坏死细胞百分比,分别对上述3项指标进行评分,再根据各指标得分之和将缺血-再灌注损伤程度划分为5级(0~Ⅳ级),统计围手术期(术后2周内)、术后近期(术后2周至1个月)、术后中远期(1个月以上)的患者死亡率。结果移植肝缺血再灌注损伤程度评为0级者157例(A组),死亡7例(4.5%),71.4%(5/7)死于术后3-6个月;缺血-再灌注损伤程度评为Ⅰ级者25例(B组),死亡5例(20.0%),80.0%(4/5)死于术后2周至3个月;缺血-再灌注损伤程度评为Ⅱ级者23例(C组),死亡5例(21.7%),80.0%(4/5)死于术后2周至3个月;缺血-再灌注损伤程度评为Ⅲ级者8例(D组),死亡7例(87.5%),85.7%(6/7)死于术后1个月内;缺血-再灌注损伤程度评为Ⅳ级者5例(E组),全部死亡,80.0%(4/5)死于术后1个月内。A组各期死亡率明显低于B组、C组(P〈0.05)和D组、E组(P〈0.01);B组、C组间各期死亡率的差异无统计学意义(P〉0.05);B组、C组各期死亡率均低于D组、E组(P〈0.05)。结论基础肝功能、组织氧分压以及水变性和坏死细胞百分比三项指标可基本反映移植肝缺血-再灌注损伤程度;缺血-再灌注损伤评级达Ⅲ~Ⅳ级者术后死亡率较高。 相似文献
72.
H. Newell J. D. Smith P. Rogers E. Birks A. J. Danskine R. E. Fawson M. L. Rose 《American journal of transplantation》2006,6(7):1712-1717
Implantation of left ventricular assist devices (LVAD) is associated with HLA antibody sensitization. The objective of this study was to determine the specificity of antibodies produced by LVAD recipients using a combination of ELISA, Luminex and microcytotoxicity assays. Fifty-one LVAD patients were studied, from 44 to 838 days post-implantation. No patient developed HLA antibodies, although 24 produced IgG antibodies detectable in both ELISA and Luminex assays. These antibodies manifest as positive reactions with class I and class II wells of the ELISA and also blank wells. In Luminex assays, they produce high MFI readings with the negative control beads. Antibodies were detected 18 to 228 days after implantation. This reactivity was found to be directed against bovine serum albumin (BSA), commonly used to block non-specific binding in ELISA and Luminex assays; absorption of sera with BSA-coated beads completely abrogated reactivity in all solid phase assays, but did not eliminate anti-HLA antibodies in control sera. Ten of the 24 patients have proceeded to transplantation, with a 1-year graft survival of 69%. In conclusion, it appears that implantation of LVADS disrupts immunoregulatory pathways leading to production of anti-albumin antibodies. These can be misinterpreted as anti-HLA antibodies in solid phase assays. 相似文献
73.
趾蹼血管分型的临床认识 总被引:2,自引:2,他引:0
目的分析120例足趾移植再造手指病例,对趾蹼间的血管形态和交通情况进行观察,并阐述其临床意义。方法临床观察120例156侧趾蹼,对第一跖骨背动脉和第一趾底动脉在趾蹼间的走向、口径以及两者的交通支情况进行记录并进行分型。结果按孙博的分型方法:Ⅰ型72侧,占46.2%;Ⅱ型57侧,占36.5%;Ⅱ型7侧,占4.5%;Ⅳ型3侧,占1.9%;Ⅴ型15侧,占9.6%;另有2侧(占1.3%)第一跖骨背血管口径〉1mm,虽发出趾背动脉供养蹲趾胫侧和第二趾腓侧,但在趾蹼内与趾底血管无吻合,故称之为孙博Ⅵ型。结论(1)从解剖形态看应增加孙博Ⅵ型较全面;(2)从临床实用角度出发,趾蹼间血管可以简单分为三型:Ⅰ型交通支口径在0.5mm以上。Ⅱ型交通支在0.5mm以下。Ⅲ型无交通;(3)手术中采用第一套或第二套供血系统,首先要看趾蹼间血管的交通支,即按本组的分型属Ⅰ型采用第一套供血系统,Ⅱ、Ⅲ型采用第二套供血系统。 相似文献
74.
目的探讨磁共振成像在肝移植并发症诊断中的价值。方法回顾分析11例肝移植术后发生并发症者的磁共振检查影像资料。结果11例患者术后出现皮肤和巩膜黄染、发热以及尿黄等症状,丙氨酸转氨酶、天冬氨酸转氨酶、γ-谷氨酰转移酶和胆红素升高.经B型超声波检查不能明确原因,采用磁共振(MRI、MRA和MRCP)检查,明确肝动脉吻合口狭窄1例;肝动脉闭塞2例;下腔静脉吻合口狭窄及血栓形成各1例;胆管吻合口狭窄4例,其中1例伴胆汁瘤形成;肝门水平非吻合口狭窄6例;肝坏死2例;肝包膜下血肿及右肾上腺出血各1例;均显示不等量的右侧胸腔积液、腹腔积液及肝门部水肿。结论磁共振一次检查可显示肝内外的多种结构,能为肝移植术后并发症的诊断提供丰富的肝脏、血管、胆道以及肝外结构的图像信息。 相似文献
75.
76.
目的总结原位肝移植手术的临床经验,探讨提高肝移植手术效果的措施。方法回顾分析2003年12月~2006年3月30例原位肝移植患者的临床资料,均采用同种异体(尸体供肝)原位全肝移植,其中经典式24例,背驮式6例。结果30例手术全部成功,供肝热缺血时间平均4.5 m in,冷缺血时间5 h。围术期死亡3例。与手术相关主要并发症有:腹腔内出血4例,门静脉狭窄2例,胆道吻合口狭窄1例、胰漏1例、胸腔积液5例。27例获随访3~30个月,1例术后3月死于胆道铸型综合征并感染,肝癌复发2例。结论确保供肝质量是肝移植成功的前提,良好的血管和胆管重建技术是肝移植手术成功的关键,专业化的围手术期处理可有效地减少并发症的发生。 相似文献
77.
Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation 总被引:3,自引:0,他引:3
Yong Wang Zheng Tang Shuming Ji Zhen Zhang Jinsong Chen Zhen Cheng Dongrui Cheng Zhihong Liu Leishi Li 《Transplant international》2006,19(12):1006-1013
The aim of the study was to analyse the clinical manifestation and management of pulmonary Lophomonas blattarum infection in four allograft transplantation recipients retrospectively. Four patients with pulmonary L. blattarum infection were diagnosed by using Fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage (BAL) examination. Their clinical manifestation and management are summarized. Four cases of pulmonary L. blattarum were found during the period from the second month to the third month after transplantation. Concurring infection by other pathogens was found in three of them. Common initial symptoms included fever (>38 degrees C) without cough and breathlessness. Lower lobe shadowing could be found on chest X-ray. Body temperature decreased to the normal range in three patients and to 37.5 degrees C in the other one, after intravenous injection of metronidazole and tapering immunosuppressant. Radiological examination confirmed improved health condition of the patients afterwards. Two patients received repeated FOB and only dead L. blattarum was found. Pulmonary L. blattarum infection in allograft transplant recipients carry relatively obscure initial symptoms. Possible L. blattarum infection needs to be screened in post-transplantation pulmonary infection patients with similar symptoms, especially in those who respond poorly to anti-infection treatment. Microscopic examination of BAL fluid can help to identify pulmonary L. blattarum infection and metronidazole is an ideal treatment choice. 相似文献
78.
C. Ballet G. Roussey-Kesler J.-T. Aubin S. Brouard M. Giral P. Miqueu S. Louis S. van der Werf J.-P. Soulillou 《American journal of transplantation》2006,6(11):2796-2801
Rare kidney allograft recipients enjoy unaltered graft function years after interruption of their immunosuppressive treatment. To assess the extent to which this state of 'operational tolerance' (TOL) is specific to the graft and not the result of a global immunodeficiency, we analyzed the response of such patients following influenza vaccination. Hemagglutination inhibition titers and frequency of IFNgamma-secreting T cells were measured before 1 and 3 months after vaccination. The proportion of healthy volunteers (HV) responding to vaccine was significantly higher than that of immunosuppressed (IS) patients. Three 'TOL' patients presented a humoral response similar to that of HV, whereas the two others had a poor response, like the IS recipients. Although the small number of patients does not allow for definitive conclusions to be made, these data suggest that the status of tolerance may be heterogeneous, with some patients with a global immunodeficiency and others with an adapted response to vaccination. 相似文献
79.
目的:使用动态增强MR成像技术获得的肝灌注系数(HPI),评价其在反映肝移植前晚期肝硬化患者肝脏血供特点中的价值。方法:使用1.5T MR扫描仪对100例正常肝脏组和57例晚期肝硬化患者移植前的受体肝脏进行快速团注对比剂(Gd-DTPA)后的斜冠状断面单层2D SPGR序列的MR灌注成像检查,比较对照组和肝硬化组门静脉和肝实质的时间-信号强度变化曲线(TIC)特点及峰值时间。根据腹腔干水平腹主动脉和门静脉主干的TIC为参照设置时间参数,计算受检者肝脏实质动脉期和静脉期的正增强系数(PEI)。设定肝灌注系数(HPI)=动脉期PEI/(动脉期PEI 门脉期PEI)×100%。对两组受检者HPI进行统计分析,根据HPI的受试者工作特性曲线(receiver operator characteristiccurve,ROCcurve)选择诊断肝硬化的HPI参考标准。结果:对照组及肝硬化组门静脉曲线峰值时间分别为(38.66±4.14)s和(55.51±5.31)s,P<0.01;肝实质TIC峰值时间分别为(56.24±4.47)s和(81.39±7.02)s,P<0.01;对照组及肝硬化组肝实质的HPI分别为(18.9±3.5)%和(26.4±5.5)%,P<0.01;应用HPI>21.6%为诊断肝硬化的标准,敏感度为86%,特异度为85%,阳性预测值为77%,阴性预测值为91%,诊断符合率为85%。结论:MR灌注成像技术可以在活体状态下无创分析肝内血供,此技术可用于评估晚期肝硬化患者肝移植前肝脏内的血流灌注。 相似文献
80.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献